Cite
HARVARD Citation
Yang, G. et al. (n.d.). Endogenous interleukin-22 protects against inflammatory bowel disease but not autoimmune cholangitis in dominant negative form of transforming growth factor beta receptor type II mice. Clinical and experimental immunology. pp. 154-164. [Online].